116 related articles for article (PubMed ID: 17119372)
1. Overview: drug eluting stents.
Dauerman HL
Coron Artery Dis; 2006 Dec; 17(8):657-9. PubMed ID: 17119372
[No Abstract] [Full Text] [Related]
2. Drug eluting stents for everyone and everything?
Laham RJ
Catheter Cardiovasc Interv; 2005 Dec; 66(4):512-3. PubMed ID: 16270362
[No Abstract] [Full Text] [Related]
3. Promise and challenges of bioabsorbable stents.
Waksman R
Catheter Cardiovasc Interv; 2007 Sep; 70(3):407-14. PubMed ID: 17722019
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
Carter AJ
Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681
[No Abstract] [Full Text] [Related]
5. Drug-eluting stents for the prevention of restenosis: Standing the test of time.
Carter AJ
Catheter Cardiovasc Interv; 2002 Sep; 57(1):69-71. PubMed ID: 12203932
[No Abstract] [Full Text] [Related]
6. Benefits of drug-eluting stents in coronary heart disease treatment with emphasis on the diabetic subgroup.
Nguyen MC; Lim YL
Heart Lung Circ; 2007 Feb; 16(1):7-9. PubMed ID: 17169611
[No Abstract] [Full Text] [Related]
7. Preventing restenosis with stent drug coatings.
Belardi J
J Invasive Cardiol; 2002 Sep; 14(9):576-82. PubMed ID: 12369563
[No Abstract] [Full Text] [Related]
8. Polymer coating techniques for drug-eluting stents.
al-Lamee K; Cook D
Med Device Technol; 2003; 14(1):12-4. PubMed ID: 12974119
[TBL] [Abstract][Full Text] [Related]
9. Major polymer damage of drug-eluting stents.
Wiemer M; Butz T; Mahmood K; Horstkotte D
Circ Cardiovasc Interv; 2008 Oct; 1(2):154. PubMed ID: 20031670
[No Abstract] [Full Text] [Related]
10. Designer stents and restenosis.
Vetrovec GW
Catheter Cardiovasc Interv; 2003 Oct; 60(2):179. PubMed ID: 14517921
[No Abstract] [Full Text] [Related]
11. Two-stent techniques for the treatment of coronary bifurcations with drug-eluting stents.
Iakovou I; Colombo A
Hellenic J Cardiol; 2005; 46(3):188-98. PubMed ID: 15981554
[No Abstract] [Full Text] [Related]
12. Cypher versus Taxus: all smoke and no fire: lessons for future comparative drug-eluting stent trials in interventional cardiology.
Buch AN; Waksman R
Am J Cardiol; 2007 Feb; 99(3):424-7. PubMed ID: 17261412
[No Abstract] [Full Text] [Related]
13. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting versus third-generation bare metal stents: the US strategy.
Isenbarger DW; Resar JR
Int J Cardiovasc Intervent; 2005; 7(4):171-5. PubMed ID: 16373262
[TBL] [Abstract][Full Text] [Related]
15. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
Young JJ
Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
[TBL] [Abstract][Full Text] [Related]
16. [Restenosis in a cobalt-chromium stent 36 months after implantation into the right coronary artery].
Koziński M; Rychter M; Gadzińska A; Sukiennik A; Kubica J
Kardiol Pol; 2008 Sep; 66(9):1002-6; discussion 1007. PubMed ID: 18924034
[No Abstract] [Full Text] [Related]
17. Carotid artery in-stent restenosis resolved with drug-eluting stenting.
Iancu A; Lazar A
J Invasive Cardiol; 2007 Jul; 19(7):315. PubMed ID: 17620678
[No Abstract] [Full Text] [Related]
18. Choice of stents -- Balancing subacute thrombosis and restenosis.
Sethi KK; Lahiri S
Indian Heart J; 2009; 61(1):61-7. PubMed ID: 19729692
[No Abstract] [Full Text] [Related]
19. Newer stents: looking at the horizon.
Ramcharitar S; Serruys PW
Indian Heart J; 2007; 59(2 Suppl B):B59-71. PubMed ID: 19153438
[TBL] [Abstract][Full Text] [Related]
20. Is zero enough?
Gonschior P
J Invasive Cardiol; 2002 Sep; 14(9):514. PubMed ID: 12205349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
